Affiliations 

  • 1 a Division of Hematology and Stem Cell Transplantation, Department of Medicine , Universiti Kebangsaan Malaysia (UKM) , Jalan Yaacob Latif, Bandar Tun Razak, 56000 Kuala Lumpur , Malaysia
  • 2 b Division of Neurology, Department of Medicine , Universiti Kebangsaan Malaysia (UKM) , Jalan Yaacob Latif, Bandar Tun Razak, 56000 Kuala Lumpur , Malaysia
  • 3 c Department of Ophthalmology, Faculty of Medicine , Universiti Kebangsaan Malaysia (UKM) , Jalan Yaacob Latif, Bandar Tun Razak, 56000 Kuala Lumpur , Malaysia
Hematology, 2001;6(4):267-9.
PMID: 27414846 DOI: 10.1080/10245332.2001.11752124

Abstract

Leukemic infiltration of the optic nerve is rare [1]. [Camera, A., Piccirillo, G., Tranfa, F., Rosa, N., Frigeri, F., Martinelli, V., Rotoloi, B. (1993) "Optic nerve involvement in acute lymphoblastic leukemia", Leuk. Lymph. 11, 153-155]. Radiotherapy should be given urgently to all patients with optic nerve infiltrate to restore their vision [2]. [Rosenthal, A. (1983) "Ocular manifestation of leukemia", Ophthalmology 90, 899-905]. We report a case of a unilateral optic nerve relapse 7 months after diagnosis of acute lymphoblastic leukemia (ALL) in a 17-year-old boy who had been off treatment for 6 weeks. The ocular symptoms was initially diagnosed as primary optic neuritis and treated with corticosteroids resulting in temporary clinical recovery. Radiation therapy for ocular leukemia that was commenced 2 months after the onset of symptoms failed to reverse the visual loss. The lack of a reliable and effective tool to diagnose ocular leukemia at an early stage has resulted in significant treatment delay and poor visual outcome.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.